Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ® (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the closing ...
Vivasure Medical Limited — a developer of advanced polymer implants and delivery systems for cardiology, interventional radiology, and vascular surgery — recently announced it had been granted an ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the first patient treated with PerQseal ® ...
Abbott Park, IL - The US Food and Drug Administration has approved the StarClose vascular closure system (Abbott), used for femoral-artery closure following diagnostic catheterization procedures, the ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Cardinal Health said Wednesday that it will spend $320 million to acquire AccessClosure and its extravascular closure devices technology.AccessClosure's Mynx family of patient-friendly vascular ...
Vivasure Medical Ltd. received CE mark approval for its Perqseal Elite vascular closure system which manages bleeding complications associated with large-bore arterial vessel closure. The sutureless, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results